Summary
Byung-chun Yoo is a director-level biotechnology leader with nine years of industry experience and over two decades in academic and translational research, specializing in IND-enabling gene and cell therapy development and CRISPR/Cas9 genome editing. He blends hands-on molecular and biochemical expertise—ranging from multiplex gRNA design, high-throughput assay development, and recombinant protein production—to strategic roles in business development, IP strategy, and clinical protocol coordination. As a former CTO and Chief Research Officer, he has led technology optimization for gene therapy pipelines, filed provisional patents, and scaled HTP operations to tens of thousands of samples. He also serves as an adjunct professor guiding graduate research, underscoring a rare mix of practical commercialization experience and sustained academic mentorship. Colleagues know him for turning complex bench workflows into robust, IND-ready processes and for leveraging curiosity-driven problem solving to streamline discovery-to-clinic transitions.
9 years of coding experience
10 years of employment as a software developer
software development, software development at ZipCode of Wilmington
Bachelor’s Degree, Food Science and Technology, Bachelor’s Degree, Food Science and Technology at Korea University
Doctor of Philosophy (Ph.D.), Biochemistry and Molecular Biology, Doctor of Philosophy (Ph.D.), Biochemistry and Molecular Biology at University of Florida
English, Korean